MARTINUCCI, IRENE
 Distribuzione geografica
Continente #
NA - Nord America 3.067
AS - Asia 920
EU - Europa 803
SA - Sud America 107
Continente sconosciuto - Info sul continente non disponibili 83
AF - Africa 51
OC - Oceania 4
Totale 5.035
Nazione #
US - Stati Uniti d'America 2.995
SG - Singapore 324
IT - Italia 253
CN - Cina 247
HK - Hong Kong 111
SE - Svezia 105
GB - Regno Unito 94
VN - Vietnam 88
BR - Brasile 83
DE - Germania 75
BG - Bulgaria 67
CA - Canada 50
FI - Finlandia 46
FR - Francia 45
RU - Federazione Russa 38
TR - Turchia 34
IN - India 29
CI - Costa d'Avorio 22
BD - Bangladesh 17
JP - Giappone 17
AT - Austria 16
BE - Belgio 14
MX - Messico 11
IQ - Iraq 10
KR - Corea 10
PL - Polonia 9
NL - Olanda 8
UA - Ucraina 8
NG - Nigeria 7
SN - Senegal 7
VE - Venezuela 7
CH - Svizzera 6
LT - Lituania 6
AU - Australia 4
EC - Ecuador 4
ID - Indonesia 4
MY - Malesia 4
SA - Arabia Saudita 4
SK - Slovacchia (Repubblica Slovacca) 4
ZA - Sudafrica 4
ES - Italia 3
PE - Perù 3
PH - Filippine 3
PK - Pakistan 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
CL - Cile 2
DZ - Algeria 2
EU - Europa 2
JM - Giamaica 2
JO - Giordania 2
NI - Nicaragua 2
NP - Nepal 2
PA - Panama 2
TW - Taiwan 2
UZ - Uzbekistan 2
AL - Albania 1
AO - Angola 1
AZ - Azerbaigian 1
BJ - Benin 1
BO - Bolivia 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
BW - Botswana 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
GP - Guadalupe 1
GR - Grecia 1
IE - Irlanda 1
IL - Israele 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
LY - Libia 1
PR - Porto Rico 1
PY - Paraguay 1
RW - Ruanda 1
SI - Slovenia 1
SV - El Salvador 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TZ - Tanzania 1
Totale 4.955
Città #
Ashburn 302
Woodbridge 251
Fairfield 249
Singapore 172
Houston 140
Chandler 139
Santa Clara 136
Serra 133
Seattle 122
Hong Kong 105
Ann Arbor 104
Wilmington 92
Dallas 91
Cambridge 88
San Jose 87
Sofia 67
Council Bluffs 60
New York 57
Shanghai 54
Los Angeles 49
London 45
Beijing 43
Dearborn 32
Ottawa 31
Boardman 30
Florence 28
Princeton 27
Medford 24
Lawrence 23
Abidjan 22
Des Moines 22
Lauterbourg 22
Helsinki 19
Frankfurt am Main 18
Hanoi 18
Izmir 18
Washington 17
Ho Chi Minh City 16
Munich 16
Atlanta 15
Hefei 15
Nanjing 15
Istanbul 14
Phoenix 14
Brussels 13
Orem 13
Dong Ket 12
Redondo Beach 12
Tokyo 12
Vienna 12
San Francisco 11
Southend 11
Brooklyn 8
Buffalo 8
Empoli 8
Jacksonville 8
Milan 8
Pisa 8
Seoul 8
Toronto 8
Amsterdam 7
Dakar 7
Düsseldorf 7
Falkenstein 7
Lagos 7
Lancaster 7
Nanchang 7
Turku 7
Warsaw 7
Bern 6
Chennai 6
Falls Church 6
Hebei 6
Manchester 6
Montreal 6
Redwood City 6
Changsha 5
Chicago 5
Columbus 5
Denver 5
Dhaka 5
Guangzhou 5
Haiphong 5
San Diego 5
Shenyang 5
São Paulo 5
Bexley 4
Boulder 4
Kunming 4
Rajkot 4
Rende 4
Renton 4
The Dalles 4
Auburn Hills 3
Belo Horizonte 3
Boston 3
Central 3
Da Nang 3
Detroit 3
Jeddah 3
Totale 3.406
Nome #
Voluntary and controlled weight loss can reduce symptoms and proton pump inhibitor use and dosage in patients with gastroesophageal reflux disease: A comparative study 508
Vegetal and Animal Food Proteins Have a Different Impact in the First Postprandial Hour of Impedance-pH Analysis in Patients with Heartburn 336
Symptom analysis improves GERD diagnosis and may be helpful to define a successful surgical approach 268
Gastroesophageal reflux symptoms among Italian university students: Epidemiology and dietary correlates using automatically recorded transactions 260
Randomised clinical trial: twice daily esomeprazole 40 mg vs. pantoprazole 40 mg in Barrett’s oesophagus for 1 year 230
Overlap of functional heartburn and gastroesophageal reflux disease with irritable bowel syndrome 216
Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they? 195
Gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome: Common overlapping gastrointestinal disorders 193
Genetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders 191
Manually calculated oesophageal bolus clearance time increases in parallel with reflux severity at impedance-pH monitoring 183
Barrett's esophagus in 2016: From pathophysiology to treatment 179
The pharmacokinetics of ilaprazole for gastro-esophageal reflux treatment 178
Lower pH values of weakly acidic refluxes as determinants of heartburn perception in gastroesophageal reflux disease patients with normal esophageal acid exposure 178
Esophageal motility abnormalities in gastroesophageal reflux disease 177
Alginate controls heartburn in patients with erosive and nonerosive reflux disease 174
Vonoprazan fumarate for the management of acid-related diseases 174
Esophageal testing: What we have so far 171
Impairment of chemical clearance and mucosal integrity distinguishes hypersensitive esophagus from functional heartburn 168
Vonoprazan for treatment of gastroesophageal reflux: pharmacodynamic and pharmacokinetic considerations 168
Gastrointestinal involvement in systemic sclerosis 158
Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough 151
A review of pharmacotherapy for treating gastroesophageal reflux disease (GERD) 151
Optimal management of constipation associated with irritable bowel syndrome 146
Critical appraisal of Rome IV criteria: hypersensitive esophagus does belong to gastroesophageal reflux disease spectrum 143
Optimal treatment of laryngopharyngeal reflux disease 139
Totale 5.035
Categoria #
all - tutte 14.240
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.240


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022269 0 0 9 15 54 40 6 18 17 9 13 88
2022/2023451 33 87 29 28 45 61 2 38 89 3 35 1
2023/2024181 16 15 36 8 11 42 5 3 1 16 0 28
2024/2025852 3 26 7 52 113 112 36 33 82 122 75 191
2025/2026888 76 86 97 42 144 68 146 48 58 93 19 11
2026/2027643 419 73 151 0 0 0 0 0 0 0 0 0
Totale 5.035